{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:51:35Z","timestamp":1785549095104,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Colleges and Universities in Anhui Province","award":["2025AHGXZK40536"],"award-info":[{"award-number":["2025AHGXZK40536"]}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["No. 2308085QH270"],"award-info":[{"award-number":["No. 2308085QH270"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anhui Science Fund for Distinguished Young Scholars","award":["No. 2208085J45"],"award-info":[{"award-number":["No. 2208085J45"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82370878"],"award-info":[{"award-number":["No. 82370878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017668","name":"Key Research and Development Program of Anhui Province","doi-asserted-by":"crossref","award":["No. 2022i01020023"],"award-info":[{"award-number":["No. 2022i01020023"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42992-0","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:35:03Z","timestamp":1772822103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DDR2 ameliorates nonalcoholic hepatic steatosis by activating the AMPK\/ACC pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Manyu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"42992_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"42992_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039 (2020).","journal-title":"J. Hepatol."},{"key":"42992_CR3","doi-asserted-by":"publisher","unstructured":"Eslam, M., Sanyal, A. J., George, J. & International Consensus, P. M. A. F. L. D. A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158, 1999\u20132014 e (1991). https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312 (2020).","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"42992_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121. https:\/\/doi.org\/10.1053\/j.gastro.2005.04.014 (2005).","journal-title":"Gastroenterology"},{"issue":"e1342","key":"42992_CR5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","volume":"10","author":"DL White","year":"2012","unstructured":"White, D. L., Kanwal, F. & El-Serag, H. B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin. Gastroenterol. Hepatol. 10 (e1342), 1342\u20131359. https:\/\/doi.org\/10.1016\/j.cgh.2012.10.001 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"42992_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-00747-9","author":"H Ledford","year":"2024","unstructured":"Ledford, H. First US drug approved for a liver disease surging around the world. Nature https:\/\/doi.org\/10.1038\/d41586-024-00747-9 (2024).","journal-title":"Nature"},{"key":"42992_CR7","doi-asserted-by":"publisher","first-page":"105484","DOI":"10.1016\/j.phrs.2021.105484","volume":"167","author":"N Sodum","year":"2021","unstructured":"Sodum, N., Kumar, G., Bojja, S. L., Kumar, N. & Rao, C. M. Epigenetics in NAFLD\/NASH: Targets and therapy. Pharmacol. Res. 167, 105484. https:\/\/doi.org\/10.1016\/j.phrs.2021.105484 (2021).","journal-title":"Pharmacol. Res."},{"key":"42992_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","volume":"59","author":"F Nascimbeni","year":"2013","unstructured":"Nascimbeni, F. et al. From NAFLD in clinical practice to answers from guidelines. J. Hepatol. 59, 859\u2013871. https:\/\/doi.org\/10.1016\/j.jhep.2013.05.044 (2013).","journal-title":"J. Hepatol."},{"key":"42992_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","volume":"63","author":"SE Keating","year":"2015","unstructured":"Keating, S. E. et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J. Hepatol. 63, 174\u2013182. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.022 (2015).","journal-title":"J. Hepatol."},{"key":"42992_CR10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/oby.2008.201","volume":"16","author":"DE Larson-Meyer","year":"2008","unstructured":"Larson-Meyer, D. E. et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obes. (Silver Spring). 16, 1355\u20131362. https:\/\/doi.org\/10.1038\/oby.2008.201 (2008).","journal-title":"Obes. (Silver Spring)"},{"key":"42992_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343\u20131351. https:\/\/doi.org\/10.1172\/JCI23621 (2005).","journal-title":"J. Clin. Invest."},{"key":"42992_CR12","doi-asserted-by":"publisher","unstructured":"Siddiqui, M. S. et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol 13, 1000\u20131008 e1003, (2015). https:\/\/doi.org\/10.1016\/j.cgh.2014.10.008","DOI":"10.1016\/j.cgh.2014.10.008"},{"key":"42992_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","volume":"134","author":"E Fabbrini","year":"2008","unstructured":"Fabbrini, E. et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424\u2013431. https:\/\/doi.org\/10.1053\/j.gastro.2007.11.038 (2008).","journal-title":"Gastroenterology"},{"key":"42992_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","volume":"28","author":"M Adiels","year":"2008","unstructured":"Adiels, M., Olofsson, S. O., Taskinen, M. R. & Boren, J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc Biol. 28, 1225\u20131236. https:\/\/doi.org\/10.1161\/ATVBAHA.107.160192 (2008).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"42992_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s1262-3636(07)70061-7","volume":"29","author":"F Diraison","year":"2003","unstructured":"Diraison, F., Moulin, P. & Beylot, M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29, 478\u2013485. https:\/\/doi.org\/10.1016\/s1262-3636(07)70061-7 (2003).","journal-title":"Diabetes Metab."},{"key":"42992_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert, J. E., Ramos-Roman, M. A., Browning, J. D. & Parks, E. J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726\u2013735. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.049 (2014).","journal-title":"Gastroenterology"},{"key":"42992_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejphar.2015.01.033","volume":"751","author":"GX Ju","year":"2015","unstructured":"Ju, G. X., Hu, Y. B., Du, M. R. & Jiang, J. L. Discoidin domain receptors (DDRs): potential implications in atherosclerosis. Eur. J. Pharmacol. 751, 28\u201333. https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.033 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"42992_CR18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1096\/fj.02-0320fje","volume":"17","author":"W Matsuyama","year":"2003","unstructured":"Matsuyama, W., Kamohara, H., Galligan, C., Faure, M. & Yoshimura, T. Interaction of discoidin domain receptor 1 isoform b (DDR1b) with collagen activates p38 mitogen-activated protein kinase and promotes differentiation of macrophages. FASEB J. 17, 1286\u20131288. https:\/\/doi.org\/10.1096\/fj.02-0320fje (2003).","journal-title":"FASEB J."},{"key":"42992_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/jbmr.225","volume":"26","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J. Bone Min. Res. 26, 604\u2013617. https:\/\/doi.org\/10.1002\/jbmr.225 (2011).","journal-title":"J. Bone Min. Res."},{"key":"42992_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000374054","volume":"36","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Nrp1, a Neuronal Regulator, Enhances DDR2-ERK-Runx2 Cascade in Osteoblast Differentiation via Suppression of DDR2 Degradation. Cell. Physiol. Biochem. 36, 75\u201384. https:\/\/doi.org\/10.1159\/000374054 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"42992_CR21","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jbmr.159","volume":"25","author":"KL Lin","year":"2010","unstructured":"Lin, K. L. et al. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J. Bone Min. Res. 25, 2489\u20132503. https:\/\/doi.org\/10.1002\/jbmr.159 (2010).","journal-title":"J. Bone Min. Res."},{"key":"42992_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11248-013-9751-2","volume":"23","author":"I Kawai","year":"2014","unstructured":"Kawai, I. et al. Discoidin domain receptor 2 (DDR2) regulates body size and fat metabolism in mice. Transgenic Res. 23, 165\u2013175. https:\/\/doi.org\/10.1007\/s11248-013-9751-2 (2014).","journal-title":"Transgenic Res."},{"key":"42992_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41418-021-00887-9","volume":"29","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Targeting adipocytic discoidin domain receptor 2 impedes fat gain while increasing bone mass. Cell. Death Differ. 29, 737\u2013749. https:\/\/doi.org\/10.1038\/s41418-021-00887-9 (2022).","journal-title":"Cell. Death Differ."},{"key":"42992_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1051\/jbio\/2020007","volume":"214","author":"F Lachkar","year":"2020","unstructured":"Lachkar, F., Papaioannou, A., Ferre, P. & Foufelle, F. [ER stress and NAFLD]. Biol. Aujourdhui. 214, 15\u201323. https:\/\/doi.org\/10.1051\/jbio\/2020007 (2020).","journal-title":"Biol. Aujourdhui"},{"key":"42992_CR25","doi-asserted-by":"publisher","unstructured":"Mors, K. et al. Anti-inflammatory Effects of Alcohol Are Associated with JNK-STAT3 Downregulation in an In Vitro Inflammation Model in HepG2 Cells. Dis Markers 6622701, (2021). https:\/\/doi.org\/10.1155\/2021\/6622701 (2021).","DOI":"10.1155\/2021\/6622701"},{"key":"42992_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cmet.2012.03.004","volume":"15","author":"RV Farese Jr","year":"2012","unstructured":"Farese, R. V. Jr., Zechner, R., Newgard, C. B. & Walther, T. C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell. Metab. 15, 570\u2013573. https:\/\/doi.org\/10.1016\/j.cmet.2012.03.004 (2012).","journal-title":"Cell. Metab."},{"key":"42992_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","volume":"7","author":"SB Biddinger","year":"2008","unstructured":"Biddinger, S. B. et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell. Metab. 7, 125\u2013134. https:\/\/doi.org\/10.1016\/j.cmet.2007.11.013 (2008).","journal-title":"Cell. Metab."},{"key":"42992_CR28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1053\/j.gastro.2007.03.055","volume":"132","author":"S Parekh","year":"2007","unstructured":"Parekh, S. & Anania, F. A. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132, 2191\u20132207. https:\/\/doi.org\/10.1053\/j.gastro.2007.03.055 (2007).","journal-title":"Gastroenterology"},{"key":"42992_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686\u2013690. https:\/\/doi.org\/10.1038\/nrgastro.2013.171 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"42992_CR30","doi-asserted-by":"publisher","unstructured":"Mariadoss, A. V. A. & Wang, C. Z. Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241914895 (2023).","DOI":"10.3390\/ijms241914895"},{"key":"42992_CR31","doi-asserted-by":"publisher","first-page":"118510","DOI":"10.1016\/j.bbamcr.2019.07.005","volume":"1866","author":"NM Coelho","year":"2019","unstructured":"Coelho, N. M., Wang, A. & McCulloch, C. A. Discoidin domain receptor 1 interactions with myosin motors contribute to collagen remodeling and tissue fibrosis. Biochim. Biophys. Acta Mol. Cell. Res. 1866, 118510. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.07.005 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"42992_CR32","doi-asserted-by":"publisher","first-page":"e1549","DOI":"10.1002\/wsbm.1549","volume":"14","author":"DM Ornitz","year":"2022","unstructured":"Ornitz, D. M. & Itoh, N. New developments in the biology of fibroblast growth factors. WIREs Mech. Dis. 14, e1549. https:\/\/doi.org\/10.1002\/wsbm.1549 (2022).","journal-title":"WIREs Mech. Dis."},{"key":"42992_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3748\/wjg.v6.i6.877","volume":"6","author":"LT Wang","year":"2000","unstructured":"Wang, L. T., Zhang, B. & Chen, J. J. Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats. World J. Gastroenterol. 6, 877\u2013880. https:\/\/doi.org\/10.3748\/wjg.v6.i6.877 (2000).","journal-title":"World J. Gastroenterol."},{"key":"42992_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-015-0218-6","volume":"34","author":"B Xie","year":"2015","unstructured":"Xie, B. et al. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. J. Exp. Clin. Cancer Res. 34, 101. https:\/\/doi.org\/10.1186\/s13046-015-0218-6 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"42992_CR35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","volume":"11","author":"SA Hawley","year":"2010","unstructured":"Hawley, S. A. et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell. Metab. 11, 554\u2013565. https:\/\/doi.org\/10.1016\/j.cmet.2010.04.001 (2010).","journal-title":"Cell. Metab."},{"key":"42992_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db09-0482","volume":"59","author":"JH Um","year":"2010","unstructured":"Um, J. H. et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554\u2013563. https:\/\/doi.org\/10.2337\/db09-0482 (2010).","journal-title":"Diabetes"},{"key":"42992_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1074\/jbc.M109.056762","volume":"285","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J. Biol. Chem. 285, 115\u2013122. https:\/\/doi.org\/10.1074\/jbc.M109.056762 (2010).","journal-title":"J. Biol. Chem."},{"key":"42992_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339\u2013343. https:\/\/doi.org\/10.1038\/415339a (2002).","journal-title":"Nature"},{"key":"42992_CR39","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1007\/s00018-010-0454-z","volume":"67","author":"C Canto","year":"2010","unstructured":"Canto, C. & Auwerx, J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell. Mol. Life Sci. 67, 3407\u20133423. https:\/\/doi.org\/10.1007\/s00018-010-0454-z (2010).","journal-title":"Cell. Mol. Life Sci."},{"key":"42992_CR40","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/liv.16052","volume":"44","author":"M Arconzo","year":"2024","unstructured":"Arconzo, M. et al. Hepatic-specific Pgc-1alpha ablation drives fibrosis in a MASH model. Liver Int. 44, 2738\u20132752. https:\/\/doi.org\/10.1111\/liv.16052 (2024).","journal-title":"Liver Int."},{"key":"42992_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1alpha and PPARalpha-mediated autophagy pathway. J. Transl Med. 22, 309. https:\/\/doi.org\/10.1186\/s12967-024-05060-7 (2024).","journal-title":"J. Transl Med."},{"key":"42992_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell. Metab. 13, 376\u2013388. https:\/\/doi.org\/10.1016\/j.cmet.2011.03.009 (2011).","journal-title":"Cell. Metab."},{"key":"42992_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2337\/diabetes.54.5.1331","volume":"54","author":"M Foretz","year":"2005","unstructured":"Foretz, M. et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54, 1331\u20131339. https:\/\/doi.org\/10.2337\/diabetes.54.5.1331 (2005).","journal-title":"Diabetes"},{"key":"42992_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin, C. et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 69, 927\u2013947. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.008 (2018).","journal-title":"J. Hepatol."},{"key":"42992_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2023.01.074","volume":"649","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Ablation of myeloid discoidin domain receptor 2 exacerbates arthritis and high fat diet induced inflammation. Biochem. Biophys. Res. Commun. 649, 47\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.074 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"42992_CR46","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"42992_CR47","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"42992_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42992-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42992-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42992-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:59:55Z","timestamp":1776247195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42992-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42992"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42992-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Ethics Committee of Anhui Medical University and were carried out in strict accordance with the ARRIVE guidelines. We further confirm that every experiment adhered to all applicable ethical regulations and standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12435"}}